NYSE - Delayed Quote USD

Teladoc Health, Inc. (TDOC)

13.73 -0.01 (-0.07%)
At close: April 24 at 4:00 PM EDT
13.85 +0.12 (+0.87%)
Pre-Market: 6:24 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,602,415.00
2,602,415.00
2,406,840.00
2,032,707.00
1,093,962.00
Cost of Revenue
760,031.00
760,031.00
743,987.00
650,258.00
390,829.00
Gross Profit
1,842,384.00
1,842,384.00
1,662,853.00
1,382,449.00
703,133.00
Operating Expense
2,052,885.00
2,052,885.00
1,890,219.00
1,621,437.00
1,121,318.00
Operating Income
-210,501.00
-210,501.00
-227,366.00
-238,988.00
-418,185.00
Net Non Operating Interest Income Expense
24,500.00
24,500.00
-9,270.00
-80,365.00
-59,950.00
Other Income Expense
-33,607.00
-33,607.00
-13,426,707.00
-65,303.00
-97,858.00
Pretax Income
-219,608.00
-219,608.00
-13,663,343.00
-384,656.00
-575,993.00
Tax Provision
760.00
760.00
-3,812.00
44,137.00
-90,857.00
Net Income Common Stockholders
-220,368.00
-220,368.00
-13,659,531.00
-428,793.00
-485,136.00
Diluted NI Available to Com Stockholders
-220,368.00
-220,368.00
-13,659,531.00
-428,793.00
-485,136.00
Basic EPS
-1.34
-1.34
-84.60
-2.73
-5.36
Diluted EPS
-1.34
-1.34
-84.60
-2.73
-5.36
Basic Average Shares
162,169.56
164,578.22
161,457.12
156,939.35
90,509.23
Diluted Average Shares
162,169.56
164,578.22
161,457.12
156,939.35
90,509.23
Total Operating Income as Reported
-248,553.00
-248,553.00
-13,653,214.00
-265,631.00
-506,421.00
Total Expenses
2,812,916.00
2,812,916.00
2,634,206.00
2,271,695.00
1,512,147.00
Net Income from Continuing & Discontinued Operation
-220,368.00
-220,368.00
-13,659,531.00
-428,793.00
-485,136.00
Normalized Income
-190,306.92
-190,306.92
-233,683.00
-377,407.57
-403,198.45
Interest Income
46,782.00
46,782.00
12,674.00
776.00
--
Interest Expense
22,282.00
22,282.00
21,944.00
81,141.00
59,950.00
Net Interest Income
24,500.00
24,500.00
-9,270.00
-80,365.00
-59,950.00
EBIT
-197,326.00
-197,326.00
-13,641,399.00
-303,515.00
-516,043.00
EBITDA
153,997.00
153,997.00
-13,370,756.00
-83,894.00
-437,956.00
Reconciled Cost of Revenue
745,779.00
745,779.00
729,371.00
634,876.00
382,237.00
Reconciled Depreciation
351,323.00
351,323.00
270,643.00
219,621.00
78,087.00
Net Income from Continuing Operation Net Minority Interest
-220,368.00
-220,368.00
-13,659,531.00
-428,793.00
-485,136.00
Total Unusual Items Excluding Goodwill
-38,052.00
-38,052.00
-13,425,848.00
-70,391.00
-97,313.00
Total Unusual Items
-38,052.00
-38,052.00
-13,425,848.00
-70,391.00
-97,313.00
Normalized EBITDA
192,049.00
192,049.00
55,092.00
-13,503.00
-340,643.00
Tax Rate for Calcs
0.00
0.00
--
0.00
0.00
Tax Effect of Unusual Items
-7,990.92
-7,990.92
--
-19,005.57
-15,375.45
12/31/2020 - 6/30/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TXG 10x Genomics, Inc.
27.52
-0.22%
 
AMWL American Well Corporation
0.5338
-1.62%
 
SDGR Schrödinger, Inc.
24.04
-3.10%
 
DOCS Doximity, Inc.
23.91
-2.73%
 
VEEV Veeva Systems Inc.
200.52
-0.29%
 
GDRX GoodRx Holdings, Inc.
6.96
-0.14%
 
GEHC GE HealthCare Technologies Inc.
86.72
+0.56%
 
SOLV Solventum Corporation
63.54
+0.06%
 
MNDR Mobile-health Network Solutions
23.88
+3.83%
 
PGNY Progyny, Inc.
32.60
+0.62%